ClinicalTrials.govpublic full text
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
triple negative breast cancer, clear cell renal cell carcinoma, ovarian cancer, head and neck cancer, colorectal cancer, non-small cell lung cancer, melanoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 885479
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.